Both in Pharmaceuticals
ALX Oncology Holdings vs Akebia Therapeutics
Over the past year ALXO returned −6.8% and AKBA returned −66.8%; their daily moves had a correlation of 0.20.
ALXO −6.8% AKBA −66.8%Growth of $1, one year, split-adjusted
| Metric | ALXO | AKBA |
|---|---|---|
| Price | $1.36 | $0.6947 |
| Market cap | $188.1M | $192.5M |
| Today | +5.43% | −4.28% |
| 1 month | +22.5% | −20.9% |
| 6 months | −34.9% | −53.1% |
| Year to date | +20.4% | −56.9% |
| 1 year | −13.4% | −67.2% |
| Revenue growth (YoY) | — | −21.4% |
| Gross margin | — | 78.8% |
| Net margin | — | −18.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.9× |
| Net cash | $128.5M | $106.0M |
| Dividend yield | — | — |
| Volatility (60d) | 93.1% | 72.3% |
| Short % of float | 6.5% | 8.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).